Skip to Main Content

Author Details

Justin Westhuyzen
Mid North Coast Cancer Institute
1976
102
23
PMIDPaper TitleJournal TitlePublished Year
36148621Clinical evaluation of deep learning and atlas-based auto-segmentation for critical organs at risk in radiation therapy.J Med Radiat Sci2023
37197610Androgen Receptor Status in Triple Negative Breast Cancer: Does It Correlate with Clinicopathological Characteristics?Breast Cancer (Dove Med Press)2023
34821471Evaluation of apical clips placed during axillary dissection demonstrates potential under-coverage of axillary radiation therapy target volumes during breast cancer regional nodal irradiation.J Med Imaging Radiat Oncol2022
35181616Prognostic Value of the Neutrophil-Lymphocyte Ratio in Triple Negative Breast Cancer Patients.Ann Clin Lab Sci2022
34288566Retrospective evaluation of planning margins for patients undergoing radical radiation therapy treatment for bladder cancer using volumetric modulated arc therapy and cone beam computed tomography.J Med Radiat Sci2021
33637119Assessment of genetic referrals and outcomes for women with triple negative breast cancer in regional cancer centres in Australia.Hered Cancer Clin Pract2021
34992870Patterns of relapse following hippocampal avoidance prophylactic cranial irradiation for small cell lung carcinoma.Rep Pract Oncol Radiother2021
34276997Metaplastic carcinoma of the breast: Clinicopathological features and treatment outcomes with long-term follow up.Mol Clin Oncol2021
32543013Long-term outcomes of patients with conserved breast cancer treated with adjuvant hypofractionated prone breast intensity-modulated radiation therapy.J Med Imaging Radiat Oncol2020
32021576Choosing between conventional and hypofractionated prostate cancer radiation therapy: Results from a study of shared decision-making.Rep Pract Oncol Radiother2020
32184654Effect of Clinical and Treatment Factors on Survival Outcomes of Triple Negative Breast Cancer Patients.Breast Cancer (Dove Med Press)2020
30505239Analysis of a volumetric-modulated arc therapy (VMAT) single phase prostate template as a class solution.Rep Pract Oncol Radiother2019
31668514PSMA-PET guided dose-escalated volumetric arc therapy (VMAT) for newly diagnosed lymph node positive prostate cancer: Efficacy and toxicity outcomes at two years.Radiother Oncol2019
31520465Late toxicities of prostate cancer radiotherapy with and without hydrogel SpaceAOR insertion.J Med Imaging Radiat Oncol2019
29760597Application of an incident taxonomy for radiation therapy: Analysis of five years of data from three integrated cancer centres.Rep Pract Oncol Radiother2018
28883765Software-based evaluation of a class solution for prostate IMRT planning.Rep Pract Oncol Radiother2017
28151584Can a peri-rectal hydrogel spaceOAR programme for prostate cancer intensity-modulated radiotherapy be successfully implemented in a regional setting?J Med Imaging Radiat Oncol2017
27721671Prostate intensity-modulated radiotherapy planning in seven mouse clicks: Development of a class solution for cancer.Rep Pract Oncol Radiother2016
27741382Tangential intensity modulated radiation therapy (IMRT) to the intact breast.J Med Radiat Sci2016
27648282Use of a prospective cohort study in the development of a bladder scanning protocol to assist in bladder filling consistency for prostate cancer patients receiving radiation therapy.J Med Radiat Sci2016
27648281Toxicity and dosimetric analysis of non-small cell lung cancer patients undergoing radiotherapy with 4DCT and image-guided intensity modulated radiotherapy: a regional centre's experience.J Med Radiat Sci2016
25382755Hyperbaric oxygen therapy for chronic radiation-induced tissue injuries: Australasia's largest study.Asia Pac J Clin Oncol2015
26229651Evaluation of atlas-based auto-segmentation software in prostate cancer patients.J Med Radiat Sci2014
20164823Early intervention with erythropoietin does not affect the outcome of acute kidney injury (the EARLYARF trial).Kidney Int2010
20459852Urinary cystatin C is diagnostic of acute kidney injury and sepsis, and predicts mortality in the intensive care unit.Crit Care2010
18275495Early detection of acute kidney injury: emerging new biomarkers.Nephrology (Carlton)2008
17127725Cystatin C: a promising marker and predictor of impaired renal function.Ann Clin Lab Sci2006
17009078Efficacy, safety and tolerability of atorvastatin in dyslipidemic subjects with advanced (non-nephrotic) and endstage chronic renal failure.Clin Exp Nephrol2006
15752373Dosing strategy for enoxaparin in patients with renal impairment presenting with acute coronary syndromes.Br J Clin Pharmacol2005
15830709Predicting clinical outcomes in peritoneal dialysis patients using small solute modeling.Ann Clin Lab Sci2005
15827344High ambient glucose is effect neutral on cell death and proliferation in human proximal tubular epithelial cells.Am J Physiol Renal Physiol2005
15522900High molecular weight plasma proteins induce apoptosis and Fas/FasL expression in human proximal tubular cells.Nephrol Dial Transplant2005
12661892Oxidative stress and erythrocyte integrity in end-stage renal failure patients hemodialysed using a vitamin E-modified membrane.Ann Clin Lab Sci2003
12584277Measurement of tubular enzymuria facilitates early detection of acute renal impairment in the intensive care unit.Nephrol Dial Transplant2003
11840368Safety and efficacy of simvastatin in hypercholesterolemic patients undergoing chronic renal dialysis.Am J Kidney Dis2002
11199319Evaluation of a novel vitamin E coated cellulosic membrane hollow fiber dialyzer.ASAIO J2001
11382690Effect of lipid-lowering dietary recommendations on the nutritional intake and lipid profiles of chronic peritoneal dialysis and hemodialysis patients.Am J Kidney Dis2001
10807156Review: Biology and relevance of C-reactive protein in cardiovascular and renal disease.Ann Clin Lab Sci2000
10945571Are metalloproteins and acute phase reactants associated with cardiovascular disease in end-stage renal failure?Ann Clin Lab Sci2000
10534515Comparison of low-molecular-weight heparin (enoxaparin sodium) and standard unfractionated heparin for haemodialysis anticoagulation.Nephrol Dial Transplant1999
9829473Folate supplementation in the dialysis patient--fragmentary evidence and tentative recommendations.Nephrol Dial Transplant1998
9491286Comparative response to single or divided doses of parenteral iron for functional iron deficiency in hemodialysis patients receiving erythropoietin (EPO).Clin Nephrol1998
8997452The oxidation hypothesis of atherosclerosis: an update.Ann Clin Lab Sci1997
9159629Effect of preoperative supplementation with alpha-tocopherol and ascorbic acid on myocardial injury in patients undergoing cardiac operations.J Thorac Cardiovasc Surg1997
9156560Simplified sizing of low-density lipoprotein using polyacrylamide gradient gel electrophoresis of plasma.Eur J Clin Chem Clin Biochem1997
9105562Oxidation of low density lipoprotein in hemodialysis patients: effect of dialysis and comparison with matched controls.Atherosclerosis1997
8836395Urinary protein excretion following coronary angiography using a non-ionic radiocontrast agent.Ann Clin Biochem1996
8871888Monitoring of extracellular and total body water during haemodialysis using multifrequency bio-electrical impedance analysis.Kidney Blood Press Res1996
7617117Evidence for oxidative stress during in vitro dialysis.Nephron1995
7988029Tubular nephrotoxicity after cardiac surgery utilising cardiopulmonary bypass.Clin Chim Acta1994
  • 1 - 50 of 102

Recommended Authors

Douglas Hayden
Massachusetts General Hospital.
Career Start Year 1997
Number of shared co-authors 0
Francois H van der Westhuizen
North-West University
Career Start Year 1996
Number of shared co-authors 0
Jean-Fran??ois Benoist
Hopital Universitaire Necker-Enfants Malades, Assistance Publique - Hopitaux de Paris
Career Start Year 1994
Number of shared co-authors 0
Thomas R Ziegler
Emory University School of Medicine
Career Start Year 1988
Number of shared co-authors 0
Nicola Di Daniele
University of Rome Tor Vergata
Career Start Year 1985
Number of shared co-authors 0
Paula K Roberson
and Clinical Center, Central Arkansas Veterans Healthcare System
Career Start Year 1984
Number of shared co-authors 0
Roberta Pastorelli
Istituto di Ricerche Farmacologiche Mario Negri IRCCS
Career Start Year 1984
Number of shared co-authors 0
Mark Levine
Molecular and Clinical Nutrition Section
Career Start Year 1983
Number of shared co-authors 0
Karen Byth
Westmead Hospital
Career Start Year 1983
Number of shared co-authors 0
Douglas C Heimburger
University of Zambia
Career Start Year 1981
Number of shared co-authors 0
John Beilby
University of Western Australia
Career Start Year 1980
Number of shared co-authors 0
Jacqueline M Hibbert
Morehouse School of Medicine
Career Start Year 1980
Number of shared co-authors 0
Dean P Jones
Clinical Biomarkers Laboratory, Emory University
Career Start Year 1978
Number of shared co-authors 0
Michael J Connor
Emory University School of Medicine
Career Start Year 1977
Number of shared co-authors 0
Robert D Stevens
Duke Molecular Physiology Institute
Career Start Year 1977
Number of shared co-authors 0
Michael Kutner
Emory University
Career Start Year 1976
Number of shared co-authors 1
James E Heubi
Cincinnati Children's Hospital Medical Center
Career Start Year 1975
Number of shared co-authors 0
Bruce A Barshop
University of California San Diego
Career Start Year 1975
Number of shared co-authors 0
Kenneth P Offord
Mayo Clinic
Career Start Year 1974
Number of shared co-authors 0
Susan T Weintraub
University of Texas Health Science Center at San Antonio Texas78229 USA.
Career Start Year 1973
Number of shared co-authors 0
Gary M Brittenham
Columbia University Vagelos College of Physicians and Surgeons
Career Start Year 1973
Number of shared co-authors 0
Peter G Lunn
Imperial Healthcare NHS Trust, Charing Cross Hospital
Career Start Year 1973
Number of shared co-authors 0
David M Koeller
Oregon Health & Science University
Career Start Year 1970
Number of shared co-authors 0
Quang Nguyen
Center for Andrology and Sexual Medicine, Viet Duc University Hospital
Career Start Year 1970
Number of shared co-authors 0
Leslie M Shaw
Perelman School of Medicine, University of Pennsylvania
Career Start Year 1968
Number of shared co-authors 0
Gilbert S Omenn
and School of Public Health, University of Michigan ann arbor
Career Start Year 1965
Number of shared co-authors 0
Gopal Krishna
ICAR-Central Institute of Fisheries Education
Career Start Year 1964
Number of shared co-authors 0
Timothy M Beasley
School of Public Health, University of Alabama at Birmingham
Career Start Year 1963
Number of shared co-authors 0
Bengt Persson
Karolinska Institutet
Career Start Year 1962
Number of shared co-authors 0
Lawrie W Powell
The University of Queensland
Career Start Year 1962
Number of shared co-authors 1

Collaborators

Zoltan H Endre
Prince of Wales Hospital and Clinical School, University of New South Wales
Co-authored papers 5
John W Pickering
Christchurch Hospital, University of Otago Christchurch
Co-authored papers 2
Robert J Walker
University of Otago
Co-authored papers 2
Christopher M Frampton
University of Otago
Co-authored papers 2
Geoffrey M Shaw
Christchurch Hospital
Co-authored papers 2
Robyn Hutchison
Co-authored papers 1
Isaac J Campbell
Co-authored papers 1
Peter M George
University of Otago
Co-authored papers 1
Robert J McGinley
Co-authored papers 1
John Schollum
Dunedin School of Medicine, University of Otago
Co-authored papers 1
Robert MacGinley
Eastern Health Clinical School, Monash University
Co-authored papers 1
Seton J Henderson
Canterbury District Health Board
Co-authored papers 1
Leo Anthony Celi
Harvard T.H. Chan School of Public Health, MIT
Co-authored papers 1
Jan Mehrtens
Christchurch Hospital
Co-authored papers 1
Jillian M Robinson
Co-authored papers 1
Release 1.2